Literature DB >> 15637308

Identification of unique lipoprotein subclasses for visceral obesity by component analysis of cholesterol profile in high-performance liquid chromatography.

Mitsuyo Okazaki1, Shinichi Usui, Masato Ishigami, Naohiko Sakai, Tadashi Nakamura, Yuji Matsuzawa, Shizuya Yamashita.   

Abstract

OBJECTIVE: The contribution of visceral fat accumulation to the development of coronary heart disease was previously reported, but the relation between visceral fat accumulation and serum lipoprotein subclasses was unknown. METHODS AND
RESULTS: We examined the relation of lipoprotein subclasses with visceral fat accumulation in 62 male subjects (aged 22 to 67 years) with visceral fat syndrome or obesity. Cholesterol levels in very low-density, low-density, and high-density lipoprotein subclasses (VLDL, LDL, and HDL) were determined by computer-assisted high-performance liquid chromatography. Subcutaneous fat area and visceral fat area were measured by computed tomographic scanning. There was no significant correlation between the subcutaneous fat area and the cholesterol levels in all lipoprotein subclasses. In contrast, the visceral fat area was correlated positively (P<0.002) with VLDL and LDL subclasses, except for large LDL, but negatively (P<0.001) with those in large and medium HDL subclasses. The observed positive correlations of small and very small LDL subclasses remained significant (P<0.005) after adjustment for serum cholesterol, triglycerides, HDL cholesterol, and LDL cholesterol, respectively, but a significant negative correlation (P<0.005) of large LDL was obtained after adjustment for LDL cholesterol.
CONCLUSIONS: These findings indicate that this simple high-performance liquid chromatography method may be applied for easy detection and evaluation of abnormal distribution of lipoprotein subclasses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15637308     DOI: 10.1161/01.ATV.0000155017.60171.88

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  69 in total

1.  High HDL cholesterol level after treatment with pitavastatin is an important factor for regression in carotid intima-media thickness.

Authors:  Kenji Okumura; Hideto Tsukamoto; Hideyuki Tsuboi; Haruo Hirayama; Haruo Kamiya; Masato Watarai; Ryoji Ishiki; Toyoaki Murohara
Journal:  Heart Vessels       Date:  2014-01-24       Impact factor: 2.037

Review 2.  Postprandial lipoprotein metabolism: VLDL vs chylomicrons.

Authors:  Katsuyuki Nakajima; Takamitsu Nakano; Yoshiharu Tokita; Takeaki Nagamine; Akihiro Inazu; Junji Kobayashi; Hiroshi Mabuchi; Kimber L Stanhope; Peter J Havel; Mitsuyo Okazaki; Masumi Ai; Akira Tanaka
Journal:  Clin Chim Acta       Date:  2011-04-19       Impact factor: 3.786

3.  Selective evaluation of high density lipoprotein from mouse small intestine by an in situ perfusion technique.

Authors:  Satoshi Yamaguchi; Bo Zhang; Takeshi Tomonaga; Utako Seino; Akiko Kanagawa; Masaru Segawa; Hironori Nagasaka; Akira Suzuki; Takashi Miida; Sohsuke Yamada; Yasuyuki Sasaguri; Takefumi Doi; Keijiro Saku; Mitsuyo Okazaki; Yoshihiro Tochino; Ken-Ichi Hirano
Journal:  J Lipid Res       Date:  2014-02-25       Impact factor: 5.922

4.  High level of serum cholesteryl ester transfer protein in active hepatitis C virus infection.

Authors:  Kenichi Satoh; Tomohisa Nagano; Nobuyoshi Seki; Yoichi Tomita; Yuta Aida; Tomonori Sugita; Munenori Itagaki; Satoshi Sutoh; Hiroshi Abe; Yoshio Aizawa
Journal:  World J Hepatol       Date:  2016-02-18

5.  In vitro screening for antihyperlipidemic activities in foodstuffs by evaluating lipoprotein profiles secreted from human hepatoma cells.

Authors:  Jyunichiro Takahashi; Gen Toshima; Yukie Matsumoto; Fumiko Kimura; Takanobu Kiuchi; Kentaro Hamada; Keishi Hata
Journal:  J Nat Med       Date:  2011-05-12       Impact factor: 2.343

6.  Mouse hepatic lipase alleles with variable effects on lipoprotein composition and size.

Authors:  Serena M Pratt; Sally Chiu; Glenda M Espinal; Noreene M Shibata; Howard Wong; Craig H Warden
Journal:  J Lipid Res       Date:  2009-11-05       Impact factor: 5.922

7.  Improved cholesterol phenotype analysis by a model relating lipoprotein life cycle processes to particle size.

Authors:  Daniël B van Schalkwijk; Albert A de Graaf; Ben van Ommen; Kees van Bochove; Patrick C N Rensen; Louis M Havekes; Niek C A van de Pas; Huub C J Hoefsloot; Jan van der Greef; Andreas P Freidig
Journal:  J Lipid Res       Date:  2009-06-10       Impact factor: 5.922

8.  Loxoprofen Sodium, a Non-Selective NSAID, Reduces Atherosclerosis in Mice by Reducing Inflammation.

Authors:  Masahide Hamaguchi; Takahiro Seno; Aihiro Yamamoto; Masataka Kohno; Masatoshi Kadoya; Hidetaka Ishino; Eishi Ashihara; Shinya Kimura; Yoshinori Tsubakimoto; Hiroki Takata; Toshikazu Yoshikawa; Taira Maekawa; Yutaka Kawahito
Journal:  J Clin Biochem Nutr       Date:  2010-07-03       Impact factor: 3.114

9.  Effects of mulberry leaf extract rich in 1-deoxynojirimycin on blood lipid profiles in humans.

Authors:  Yoshihiro Kojima; Toshiyuki Kimura; Kiyotaka Nakagawa; Akira Asai; Keiji Hasumi; Shinichi Oikawa; Teruo Miyazawa
Journal:  J Clin Biochem Nutr       Date:  2010-08-06       Impact factor: 3.114

10.  Hepatic senescence marker protein-30 is involved in the progression of nonalcoholic fatty liver disease.

Authors:  Hyohun Park; Akihito Ishigami; Toshihide Shima; Masayuki Mizuno; Naoki Maruyama; Kanji Yamaguchi; Hironori Mitsuyoshi; Masahito Minami; Kohichiroh Yasui; Yoshito Itoh; Toshikazu Yoshikawa; Michiaki Fukui; Goji Hasegawa; Naoto Nakamura; Mitsuhiro Ohta; Hiroshi Obayashi; Takeshi Okanoue
Journal:  J Gastroenterol       Date:  2009-11-28       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.